MiMedx Group Inc (MDXG)
6.155
-0.18
(-2.76%)
USD |
NASDAQ |
Apr 18, 16:00
6.155
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Gross Profit Margin (Quarterly): 84.06% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 84.06% |
| September 30, 2023 | 81.90% |
| June 30, 2023 | 83.28% |
| March 31, 2023 | 82.67% |
| December 31, 2022 | 80.68% |
| September 30, 2022 | 81.99% |
| June 30, 2022 | 82.32% |
| March 31, 2022 | 83.13% |
| December 31, 2021 | 86.03% |
| September 30, 2021 | 83.94% |
| June 30, 2021 | 81.28% |
| March 31, 2021 | 83.92% |
| December 31, 2020 | 84.22% |
| September 30, 2020 | 84.00% |
| June 30, 2020 | 84.72% |
| March 31, 2020 | 83.76% |
| December 31, 2019 | 83.37% |
| September 30, 2019 | 85.14% |
| June 30, 2019 | 85.54% |
| March 31, 2019 | 88.85% |
| December 31, 2018 | 88.76% |
| September 30, 2018 | 91.54% |
| June 30, 2018 | 90.28% |
| March 31, 2018 | 88.88% |
| December 31, 2017 | 90.58% |
| Date | Value |
|---|---|
| September 30, 2017 | 88.65% |
| June 30, 2017 | 88.70% |
| March 31, 2017 | 87.96% |
| December 31, 2016 | 83.68% |
| September 30, 2016 | 87.59% |
| June 30, 2016 | 87.11% |
| March 31, 2016 | 85.11% |
| December 31, 2015 | 90.38% |
| September 30, 2015 | 89.84% |
| June 30, 2015 | 88.86% |
| March 31, 2015 | 87.37% |
| December 31, 2014 | 90.90% |
| September 30, 2014 | 90.01% |
| June 30, 2014 | 89.29% |
| March 31, 2014 | 84.78% |
| December 31, 2013 | 82.71% |
| September 30, 2013 | 86.89% |
| June 30, 2013 | 83.73% |
| March 31, 2013 | 83.52% |
| December 31, 2012 | 83.93% |
| September 30, 2012 | 82.08% |
| June 30, 2012 | 77.17% |
| March 31, 2012 | 74.13% |
| December 31, 2011 | 65.23% |
| September 30, 2011 | 58.81% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
80.68%
Minimum
Dec 2022
86.03%
Maximum
Dec 2021
83.47%
Average
83.76%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| TELA Bio Inc | 68.38% |
| Amylyx Pharmaceuticals Inc | 91.37% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 353.3% |
| Return on Assets | 35.72% |
| Return on Invested Capital | 99.57% |
| Profit Margin (Quarterly) | 72.19% |
| Operating Margin (Quarterly) | 26.98% |
| Return on Net Operating Assets | 55.28% |